No waiting rooms, no big-city hassles, just discreet medication delivery right to your mailbox
Patients now frequently evaluate the merits of established GLP-1 receptor agonists against newer GIP/GLP-1 medications
Follow institutional protocols
Taking the time to prioritize goals and develop a thoughtful plan creates opportunities for more balanced and natural-looking outcomes
Risks associated with mass-produced compounded GLP-1s Although the FDA has declared that the supply shortage is resolved, some companies continue to mass produce compounded versions of GLP-1s, claiming that the drugs are personalized for patient needs by altering the method of delivery (e.g., gummy, injection, spray) or adding unnecessary and unproven ingredients like B12 and glycine
PMID: 32047109 J Cell Physiol Mitochondrial and Glucose Metabolic Patterns in Pre-Granulosa Cells and Oocytes and Their Dysfunctions Induce Impaired Primordial Follicle Formation in Mice